Healthcare & Life Sciences Funding

Sector profile · 680 tracked rounds · $475 billion tracked capital

Capvizr tracks Healthcare & Life Sciences funding activity across newly funded companies, lead investors, hiring signals, and market narratives.

Top company Claris BioLargest round $172 billion680 deals

Recent Healthcare & Life Sciences rounds

Claris Bio · $118 million · Series B · July 29, 2026
Lycia Therapeutics · $75 million · Funding Round · July 29, 2026
Freehand · $75 million · Series B · July 29, 2026
Mate Security · $35 million · Pre-Seed · July 29, 2026
BranchLab · $26 million · Series A · July 29, 2026
Soter Insure · $23.5 million · Series B · July 29, 2026
Henry AI · $16.5 million · Series A · July 29, 2026
Tiger Technology · $8.8 million · Pre-Seed · July 29, 2026
Adjuvia Therapeutics · $8 million · Seed · July 29, 2026
Quercus Biosolutions · $5 million · Seed · July 29, 2026

Market context

Healthcare & Life Sciences deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.

Open Healthcare & Life Sciences in the interactive Capvizr dashboard →

Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime